Evaluation of Lipid Profile and Thyroid Hormones in Breast Cancer Women
Evaluasi Profil Lipid dan Hormon Tiroid pada Wanita Kanker Payudara
DOI:
https://doi.org/10.21070/ijhsm.v1i2.34Keywords:
Breast Cancer, Lipid Profile, Thyroid HormonesAbstract
Background: Breast cancer is the foremost cause of cancer-related mortality among women globally and the second most prevalent cause of cancer death among women in the United States Aim of the Study: The study aimed to determine the association between lipid and thyroid dysregulation with breast cancer. Material and Method: A total of hundred individuals were participate in this case-control study (50 women had a breast cancer, and 50 women without disease as a control group). The study was done at Al-habobi Teaching Hospital during the period from February to June 2024. The parameters were evaluated by using Cobas 111 for biochemical tests and Cobas 411 for hormones. The Results: The study showed all level of lipid profile increased significantly in cancer patients than control group, with except the level of HDL decreased significantly in breast cancer patient. With regard thyroid hormones the study noted only the T4 decreased significantly in breast cancer patient than control group, while the other hormones not effected by disease. Conclusion: The present study concluded that lipid levels are significantly affected in women with breast cancer, while thyroid hormones are not affected by the disease
Highlights:
- Breast cancer is a leading cause of global female mortality.
- Assess lipid and thyroid dysregulation association with breast cancer.
- Lipid levels significantly altered; thyroid hormones mostly unaffected in breast cancer.
Keywords: Breast Cancer, Lipid Profile, Thyroid Hormones
References
Z. Momenimovahed and H. Salehiniya, "Epidemiological Characteristics of and Risk Factors for Breast Cancer in the World," Breast Cancer: Targets and Therapy, vol. 11, pp. 151–164, Apr. 2019.
D. Adeloye et al., "Estimating the Incidence of Breast Cancer in Africa: A Systematic Review and Meta-Analysis," Journal of Global Health, vol. 8, no. 1, Jun. 2018.
A. D. Shrestha, D. Neupane, P. Vedsted, and P. Kallestrup, "Cervical Cancer Prevalence, Incidence and Mortality in Low- and Middle-Income Countries: A Systematic Review," Asian Pacific Journal of Cancer Prevention: APJCP, vol. 19, no. 2, pp. 319–324, 2018.
M. Reyes-Farias et al., "White Adipose Tissue Dysfunction in Obesity and Aging," Biochemical Pharmacology, vol. 192, p. 114723, Oct. 2021.
S. Parrettini, M. Cavallo, F. Gaggia, R. Calafiore, and G. Luca, "Adipokines: A Rainbow of Proteins With Metabolic and Endocrine Functions," Protein and Peptide Letters, vol. 27, no. 12, pp. 1204–1230, Dec. 2020.
A. González-Ortiz et al., "Impact of Cholesterol-Pathways on Breast Cancer Development: A Metabolic Landscape," Journal of Cancer, vol. 12, no. 14, pp. 4307–4316, 2021.
C. B. Hassen et al., "Is Cholesterol a Risk Factor for Breast Cancer Incidence and Outcome?" The Journal of Steroid Biochemistry and Molecular Biology, vol. 232, p. 106346, Sep. 2023.
B. R. Gauthier et al., "Thyroid Hormones in Diabetes, Cancer, and Aging," Aging Cell, vol. 19, no. 11, p. e13260, Nov. 2020.
I. Ross, D. B. Omengan, G. N. Huang, and A. Y. Payumo, "Thyroid Hormone-Dependent Regulation of Metabolism and Heart Regeneration," Journal of Endocrinology, vol. 252, no. 3, pp. R71–R82, Mar. 2022.
B. Ren and Y. Zhu, "A New Perspective on Thyroid Hormones: Crosstalk With Reproductive Hormones in Females," International Journal of Molecular Sciences, vol. 23, no. 5, p. 2708, Feb. 2022.
I. Tawfik et al., "Breast Cancer Cells Utilize T3 to Trigger Proliferation Through Cellular Ca2+ Modulation," Cell Communication and Signaling, vol. 22, no. 1, p. 533, Nov. 2024.
D. Pei, "How Do Biomolecules Cross the Cell Membrane?" Accounts of Chemical Research, vol. 55, no. 3, pp. 309–318, Jan. 2022.
K. E. Johnson et al., "The Relationship Between Circulating Lipids and Breast Cancer Risk: A Mendelian Randomization Study," PLoS Medicine, vol. 17, no. 9, p. e1003302, Sep. 2020.
R. Vona, E. Iessi, and P. Matarrese, "Role of Cholesterol and Lipid Rafts in Cancer Signaling: A Promising Therapeutic Opportunity?" Frontiers in Cell and Developmental Biology, vol. 9, p. 622908, Mar. 2021.
A. Al-Swelmien, "Serum Lipid Profile in Breast Cancer Patients," Rawal Medical Journal, vol. 39, no. 3, pp. 254–256, Jul. 2014.
F. Ghahremanfard et al., "The Valuable Role of Measuring Serum Lipid Profile in Cancer Progression," Oman Medical Journal, vol. 30, no. 5, pp. 353–359, Sep. 2015.
X. Li et al., "The Effect of Preoperative Serum Triglycerides and High-Density Lipoprotein-Cholesterol Levels on the Prognosis of Breast Cancer," The Breast, vol. 32, pp. 1–6, Apr. 2017.
L. J. Vatten and O. P. Foss, "Total Serum Cholesterol and Triglycerides and Risk of Breast Cancer: A Prospective Study of 24,329 Norwegian Women," Cancer Research, vol. 50, no. 8, pp. 2341–2346, Apr. 1990.
K. Fan, T. Sun, and F. Yin, "LDL-C/HDL-C Ratio: A Strong Metabolic Risk Factor of Invasive Breast Cancer," [journal name missing], [year missing].
S. H. Loosen et al., "Low Blood Levels of High-Density Lipoprotein (HDL) Cholesterol Are Positively Associated With Cancer," Journal of Cancer Research and Clinical Oncology, vol. 148, no. 11, pp. 3039–3046, Nov. 2022.
K. K. Patel and K. Kashfi, "Lipoproteins and Cancer: The Role of HDL-C, LDL-C, and Cholesterol-Lowering Drugs," Biochemical Pharmacology, vol. 196, p. 114654, Feb. 2022.
L. Xu et al., "Association Between Circulating Oxidized OxLDL/LDL-C Ratio and the Severity of Coronary Atherosclerosis," Diabetes Research and Clinical Practice, vol. 191, p. 110040, Sep. 2022.
F. D. Shah et al., "Significance of Alterations in Plasma Lipid Profile Levels in Breast Cancer," Integrative Cancer Therapies, vol. 7, no. 1, pp. 33–41, Mar. 2008.
Z. U. Din et al., "Crosstalk Between Lipid Metabolism and EMT: Emerging Mechanisms and Cancer Therapy," Molecular and Cellular Biochemistry, vol. [missing], Apr. 2024.
E. Baldini et al., "Thyroid Diseases and Breast Cancer," Journal of Personalized Medicine, vol. 12, no. 2, p. 156, Feb. 2022.
M. Ghalibaf, "The Association Between Breast Cancer and Thyroid Function: From Birth to Death," Multidisciplinary Cancer Investigation, vol. 5, no. 2, pp. 1–8, Feb. 2021.
L. E. Zyla et al., "Effects of Thyroxine on Apoptosis and Proliferation of Mammary Tumors," Molecular and Cellular Endocrinology, vol. 538, p. 111454, Dec. 2021.
J. Jin et al., "Thyroid Hormone Changes Correlate to Combined Breast Cancer With Primary Thyroid Cancer," Breast Cancer: Targets and Therapy, vol. [missing], Dec. 2024.
C. M. Kitahara et al., "Thyroid Dysfunction and Cancer Incidence: A Systematic Review and Meta-Analysis," Endocrine-Related Cancer, vol. 27, no. 4, pp. 245–259, Apr. 2020.
C. H. Weng et al., "Breast Cancer Risk in Postmenopausal Women With Medical History of Thyroid Disorder in the Women's Health Initiative," Thyroid, vol. 30, no. 4, pp. 519–531, Apr. 2020.
C.-H. Weng, E. R. Okawa, M. B. Roberts, S. K. Park, C. B. Umbricht, J. E. Manson, and C. B. Eaton, "Breast Cancer Risk in Postmenopausal Women With Medical History of Thyroid Disorder in the Women's Health Initiative," Thyroid, vol. 30, no. 4, pp. 519–530, Apr. 2020, doi: 10.1089/thy.2019.0328.
L. Bach, K. Kostev, L. Schiffmann, and M. Kalder, "Association Between Thyroid Gland Diseases and Breast Cancer: A Case–Control Study," Breast Cancer Research and Treatment, vol. 182, no. 1, pp. 207–213, Jul. 2020, doi: 10.1007/s10549-020-05689-7.
B. Wang, Z. Lu, Y. Huang, R. Li, and T. Lin, "Does Hypothyroidism Increase the Risk of Breast Cancer: Evidence From a Meta-Analysis," BMC Cancer, vol. 20, pp. 1–9, Dec. 2020, doi: 10.1186/s12885-020-07582-5.
